1199 related articles for article (PubMed ID: 29498023)
21. Heart failure with preserved ejection fraction: a clinical dilemma.
Komajda M; Lam CS
Eur Heart J; 2014 Apr; 35(16):1022-32. PubMed ID: 24618346
[TBL] [Abstract][Full Text] [Related]
22. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
[TBL] [Abstract][Full Text] [Related]
23. Therapeutic approaches in heart failure with preserved ejection fraction: past, present, and future.
Wintrich J; Kindermann I; Ukena C; Selejan S; Werner C; Maack C; Laufs U; Tschöpe C; Anker SD; Lam CSP; Voors AA; Böhm M
Clin Res Cardiol; 2020 Sep; 109(9):1079-1098. PubMed ID: 32236720
[TBL] [Abstract][Full Text] [Related]
24. Significance of Ischemic Heart Disease in Patients With Heart Failure and Preserved, Midrange, and Reduced Ejection Fraction: A Nationwide Cohort Study.
Vedin O; Lam CSP; Koh AS; Benson L; Teng THK; Tay WT; Braun OÖ; Savarese G; Dahlström U; Lund LH
Circ Heart Fail; 2017 Jun; 10(6):. PubMed ID: 28615366
[TBL] [Abstract][Full Text] [Related]
25. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
[TBL] [Abstract][Full Text] [Related]
26. Characterization of heart failure patients with mid-range left ventricular ejection fraction-a report from the CHART-2 Study.
Tsuji K; Sakata Y; Nochioka K; Miura M; Yamauchi T; Onose T; Abe R; Oikawa T; Kasahara S; Sato M; Shiroto T; Takahashi J; Miyata S; Shimokawa H;
Eur J Heart Fail; 2017 Oct; 19(10):1258-1269. PubMed ID: 28370829
[TBL] [Abstract][Full Text] [Related]
27. Heart Failure with Preserved Ejection Fraction and Future Pharmacological Strategies: a Glance in the Crystal Ball.
Tschöpe C; Van Linthout S; Kherad B
Curr Cardiol Rep; 2017 Aug; 19(8):70. PubMed ID: 28656481
[TBL] [Abstract][Full Text] [Related]
28. Heart failure with mid-range ejection fraction in patients admitted to internal medicine departments: Findings from the RICA Registry.
Guisado-Espartero ME; Salamanca-Bautista P; Aramburu-Bodas Ó; Conde-Martel A; Arias-Jiménez JL; Llàcer-Iborra P; Dávila-Ramos MF; Cabanes-Hernández Y; Manzano L; Montero-Pérez-Barquero M;
Int J Cardiol; 2018 Mar; 255():124-128. PubMed ID: 29305104
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and safety of spironolactone in the heart failure with mid-range ejection fraction and heart failure with preserved ejection fraction: A meta-analysis of randomized clinical trials.
Xiang Y; Shi W; Li Z; Yang Y; Wang SY; Xiang R; Feng P; Wen L; Huang W
Medicine (Baltimore); 2019 Mar; 98(13):e14967. PubMed ID: 30921200
[TBL] [Abstract][Full Text] [Related]
30. What have we learned about heart failure with mid-range ejection fraction one year after its introduction?
Nauta JF; Hummel YM; van Melle JP; van der Meer P; Lam CSP; Ponikowski P; Voors AA
Eur J Heart Fail; 2017 Dec; 19(12):1569-1573. PubMed ID: 29067761
[TBL] [Abstract][Full Text] [Related]
31. Mineralocorticoid receptor antagonists in heart failure with preserved ejection fraction (HFpEF).
Capuano A; Scavone C; Vitale C; Sportiello L; Rossi F; Rosano GM; Coats AJ
Int J Cardiol; 2015 Dec; 200():15-9. PubMed ID: 26404747
[TBL] [Abstract][Full Text] [Related]
32. Advances in the pathophysiology and treatment of heart failure with preserved ejection fraction.
Tannenbaum S; Sayer GT
Curr Opin Cardiol; 2015 May; 30(3):250-8. PubMed ID: 25807227
[TBL] [Abstract][Full Text] [Related]
33. Impact of elevated heart rate on clinical outcomes in patients with heart failure with reduced and preserved ejection fraction: a report from the CHART-2 Study.
Takada T; Sakata Y; Miyata S; Takahashi J; Nochioka K; Miura M; Tadaki S; Shimokawa H;
Eur J Heart Fail; 2014 Mar; 16(3):309-16. PubMed ID: 24464774
[TBL] [Abstract][Full Text] [Related]
34. Drug Therapy for Acute and Chronic Heart Failure with Preserved Ejection Fraction with Hypertension: A State-of-the-Art Review.
Hiraiwa H; Okumura T; Murohara T
Am J Cardiovasc Drugs; 2024 May; 24(3):343-369. PubMed ID: 38575813
[TBL] [Abstract][Full Text] [Related]
35. Obesity-related heart failure with preserved ejection fraction: new treatment strategies.
Chrysant SG; Chrysant GS
Hosp Pract (1995); 2019 Apr; 47(2):67-72. PubMed ID: 30712418
[TBL] [Abstract][Full Text] [Related]
36. Heart failure: what does ejection fraction have to do with it?
Iwano H; Little WC
J Cardiol; 2013 Jul; 62(1):1-3. PubMed ID: 23672790
[TBL] [Abstract][Full Text] [Related]
37. Rationale and design of the phase 2b clinical trials to study the effects of the partial adenosine A1-receptor agonist neladenoson bialanate in patients with chronic heart failure with reduced (PANTHEON) and preserved (PANACHE) ejection fraction.
Voors AA; Shah SJ; Bax JJ; Butler J; Gheorghiade M; Hernandez AF; Kitzman DW; McMurray JJV; Wirtz AB; Lanius V; van der Laan M; Solomon SD
Eur J Heart Fail; 2018 Nov; 20(11):1601-1610. PubMed ID: 30225882
[TBL] [Abstract][Full Text] [Related]
38. Similarities and Differences Between HFmrEF and HFpEF.
Li P; Zhao H; Zhang J; Ning Y; Tu Y; Xu D; Zeng Q
Front Cardiovasc Med; 2021; 8():678614. PubMed ID: 34616777
[TBL] [Abstract][Full Text] [Related]
39. Heart Failure with Preserved Ejection Fraction.
Gladden JD; Chaanine AH; Redfield MM
Annu Rev Med; 2018 Jan; 69():65-79. PubMed ID: 29414252
[TBL] [Abstract][Full Text] [Related]
40. How do patients with heart failure with preserved ejection fraction die?
Chan MM; Lam CS
Eur J Heart Fail; 2013 Jun; 15(6):604-13. PubMed ID: 23610137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
